Carmot Therapeutics, Inc.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2008-01-01
- Employees
- 57
- Market Cap
- -
- Website
- http://carmot.us
Clinical Trials
7
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
A Study of CT-388 in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus
- Conditions
- Overweight or ObeseType 2 Diabetes Mellitus (T2DM)
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-10-08
- Last Posted Date
- 2025-09-16
- Lead Sponsor
- Carmot Therapeutics, Inc.
- Target Recruit Count
- 360
- Registration Number
- NCT06628362
- Locations
- 🇺🇸
Ark Clinical-Fountain Valley, Fountain Valley, California, United States
🇺🇸Pinnacle Research Group, Llc; Central, Anniston, Alabama, United States
🇺🇸Central Alabama Research, Birmingham, Alabama, United States
A Study of CT-388 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity
- First Posted Date
- 2024-07-29
- Last Posted Date
- 2025-09-11
- Lead Sponsor
- Carmot Therapeutics, Inc.
- Target Recruit Count
- 450
- Registration Number
- NCT06525935
- Locations
- 🇺🇸
Alabama Clinical Therapeutics, LLC, Birmingham, Alabama, United States
🇺🇸Central Alabama Research, Homewood, Alabama, United States
🇺🇸The Institute for Liver Health II LLC dba Arizona Clinical Trials; Arizona Liver Health, Mesa, Arizona, United States
A Study of CT-868 in Type 1 Diabetes Mellitus
- Conditions
- ObeseType 1 Diabetes MellitusOverweight
- Interventions
- First Posted Date
- 2023-10-02
- Last Posted Date
- 2025-07-17
- Lead Sponsor
- Carmot Therapeutics, Inc.
- Target Recruit Count
- 111
- Registration Number
- NCT06062069
- Locations
- 🇺🇸
John Muir Physician Network Clinical Research Center, Concord, California, United States
🇺🇸Headlands Research- AMCR, Escondido, California, United States
🇺🇸University of Colorado - Barbara Davis Center for Diabetes, Aurora, Colorado, United States
A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants with Type 1 Diabetes
- First Posted Date
- 2023-04-03
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Carmot Therapeutics, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT05794581
- Locations
- 🇺🇸
Carmot Clinical Research Unit 101, Chula Vista, California, United States
A Study of CT-868 in Overweight and Obese Participants With Type 2 Diabetes Mellitus
- First Posted Date
- 2021-11-08
- Last Posted Date
- 2022-07-26
- Lead Sponsor
- Carmot Therapeutics, Inc.
- Target Recruit Count
- 96
- Registration Number
- NCT05110846
- Locations
- 🇺🇸
Carmot Clinical Center US01, Los Angeles, California, United States
🇲🇽Carmot Clinical Center MX04, Guadalajara, Jalisco, Mexico
🇲🇽Carmot Clinical Center MX01, Monterrey, Nuevo Leon, Mexico
- Prev
- 1
- 2
- Next